Symphony Financial, Ltd. Co. Abbott Laboratories Transaction History

Symphony Financial, Ltd. Co.

$608 Million
Q3 2024

A detailed history of Symphony Financial, Ltd. Co. transactions in Abbott Laboratories stock. As of the latest transaction made, Symphony Financial, Ltd. Co. holds 8,571 shares of ABT stock, worth $983,607. This represents 0.16% of its overall portfolio holdings.

Number of Shares

8,571

Previous 7,708 11.2%

Holding current value

$983,607

Previous $800,000 22.13%

% of portfolio

0.16%

Previous 0.15%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	BUY	$100.07 - $118.13 $86,360 - $101,946	863 Added 11.2%	8,571 $977,000
Q2 2024 Jul 17, 2024	SELL	$100.73 - $112.44 $17,728 - $19,789	-176 Reduced 2.23%	7,708 $800,000
Q1 2024 Apr 17, 2024	BUY	$109.52 - $120.96 $35,155 - $38,828	321 Added 4.24%	7,884 $896,000
Q4 2023 Jan 18, 2024	BUY	$90.19 - $110.4 $451,581 - $552,772	5,007 Added 195.89%	7,563 $832,000
Q3 2023 Nov 07, 2023	BUY	$95.53 - $114.62 $49,102 - $58,914	514 Added 25.17%	2,556 $247,000
Q2 2023 Jul 12, 2023	SELL	$100.78 - $112.29 $1.8 Million - $2.01 Million	-17,898 Reduced 89.76%	2,042 $222,000
Q1 2023 May 03, 2023	SELL	$96.86 - $114.01 $239,050 - $281,376	-2,468 Reduced 11.01%	19,940 $2.02 Million
Q4 2022 Jan 26, 2023	SELL	$95.06 - $111.52 $1.21 Million - $1.42 Million	-12,737 Reduced 36.24%	22,408 $0
Q3 2022 Oct 27, 2022	BUY	$96.76 - $112.03 $101,501 - $117,519	1,049 Added 3.08%	35,145 $3.46 Million
Q2 2022 Jul 18, 2022	SELL	$102.07 - $123.37 $16,433 - $19,862	-161 Reduced 0.47%	34,096 $3.72 Million
Q1 2022 May 13, 2022	BUY	$114.02 - $139.04 $437,608 - $533,635	3,838 Added 12.62%	34,257 $4.22 Million
Q4 2021 Jan 19, 2022	BUY	$115.53 - $141.46 $751,291 - $919,914	6,503 Added 27.19%	30,419 $4.23 Million
Q3 2021 Oct 12, 2021	SELL	$116.66 - $129.06 $306,349 - $338,911	-2,626 Reduced 9.89%	23,916 $2.86 Million
Q2 2021 Jul 13, 2021	SELL	$105.79 - $124.53 $223,322 - $262,882	-2,111 Reduced 7.37%	26,542 $3.07 Million
Q1 2021 Apr 15, 2021	SELL	$108.84 - $128.23 $1.84 Million - $2.17 Million	-16,910 Reduced 37.11%	28,653 $3.43 Million
Q4 2020 Jan 13, 2021	BUY	$105.0 - $114.42 $428,610 - $467,062	4,082 Added 9.84%	45,563 $4.97 Million
Q3 2020 Oct 09, 2020	BUY	$91.64 - $111.29 $164,493 - $199,765	1,795 Added 4.52%	41,481 $4.51 Million
Q2 2020 Jul 08, 2020	BUY	$76.57 - $98.0 $667,001 - $853,678	8,711 Added 28.12%	39,686 $3.63 Million
Q1 2020 May 07, 2020	BUY	$62.82 - $91.86 $1.95 Million - $2.85 Million	30,975 New	30,975 $2.46 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $201B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Symphony Financial, Ltd. Co., based on Form 13F filings with the SEC.

News

Stay updated on Symphony Financial, Ltd. Co. with notifications on news.

Account

Symphony Financial, Ltd. Co. Abbott Laboratories Transaction History